Monthly Archives: July 2012

It depends on which tissues you’re talking about. And epigenetic modification — or at least methylation — in newborns is dictated by genetic, environmental, and tissue-specific factors, according to research published this month by Lavinia Gordon and colleagues at the Murdoch Children’s Research Institute and six other universities, research centers, and hospitals. First the tissue-based factor. Using statistical clustering, the mostly Australian multi-institutional group found that the methylation profiles of identical twins segregated into the same categories — the same general patterns of DNA modification — more often or less often, depending on the DNA’s tissue of origin. in  placental tissue, 71 percent of twin pairs’ methylation patterns “clustered” together statistically. In cord blood mononuclear cells (CBMC), identical twins shared … Continue reading

Posted in Applications, DNA Methylation, Genomewide Methylation Profiling | Tagged , , , , , | 2 Comments

In the first century A.D, Roman family Greek slaves were surgeons. Celsus wrote an encyclopedic describing their methods in latin, laying a foundation for scientific literature on medical practice and surgery. The idea of diagnosis became paramount at this time, requiring close study and record keeping of injury and disease symptoms. It was understood that some breast cancers could be extirpated with breast removal. In the 19th century, after anesthesia and antisepsis had been established, (thank heavens!) a Johns Hopkins Hospital surgeon named William Stewart Halsted introduced, perhaps, the greatest advance to breast cancer treatment. The radical mastectomy. Throughout beast cancer history, the best prognosis post treatment, seemed to be based on early stage diagnosis. (1.) Today we have exceptional … Continue reading

Posted in Biomarkers, Breast cancer, Clinical Studies, DNA Methylation, Genomewide Methylation Profiling, History & Trends, Microarray, Personalized Medicine, Transcriptome | Tagged , , , | 1 Comment

Why are tumors more common as we age? Why are we more susceptible to infection? And why does everything continue to function just a little bit worse for every day of our lives? This whole process inspired a great Kinks song. More topically, Manel Esteller thinks it might be possible to slow some of it down — maybe even reverse it. Among other roles, Dr. Esteller is editor of the journal Epigenetics and director of the Cancer Epigenetics and Biology Program at the Bellvitge Institute of Biomedical Research, known as IDIBELL. Only last week, I got to talk with Dr. Esteller about the epigenetics of aging and research he just published with colleagues comparing the genome-wide DNA methylation of newborns … Continue reading

Posted in Applications, DNA Methylation, Genomewide Methylation Profiling, Immunology, Leukemia, Oncology, Regenerative Medicine | Tagged , , , , , , , | Leave a comment